Your browser doesn't support javascript.
loading
A network meta-analysis of the association between patient traits and response to regular dosing with ICS/long-acting ß2-agonist plus short-acting ß2 agonist reliever or maintenance and reliever therapy for asthma.
Yorgancioglu, Arzu; Cruz, Alvaro A; Garcia, Gabriel; Lavoie, Kim L; Roche, Nicolas; P G, Abhijith; Verma, Manish; Majumdar, Anurita; Chatterjee, Swarnendu.
Afiliação
  • Yorgancioglu A; Department of Pulmonology, Celal Bayar University, Manisa, Turkey.
  • Cruz AA; ProAR and Universidade Federal da Bahia, Salvador, Brazil.
  • Garcia G; Respiratory Research Center, CEPIR, La Plata, Argentina.
  • Lavoie KL; University of Quebec at Montreal (UQAM), Montreal, Canada; Montreal Behavioural Medicine Centre, CIUSSS-NIM, Hopital du Sacre-Coeur de Montreal, Montreal, Canada.
  • Roche N; Pneumology, AP-HP Centre Université Paris Cité, Hôpital Cochin, Paris, France.
  • P G A; GSK, Global Medical Affairs, Global Medicine, Amsterdam, the Netherlands.
  • Verma M; GSK, Global Medical Affairs, General Medicine, Mumbai, India. Electronic address: manish.8.verma@gsk.com.
  • Majumdar A; GSK, Global Medical Affairs, General Medicine, Singapore.
  • Chatterjee S; GSK, Hyderabad, Telangana, India.
Respir Med ; 218: 107377, 2023 11.
Article em En | MEDLINE | ID: mdl-37524150
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Respir Med Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Respir Med Ano de publicação: 2023 Tipo de documento: Article